 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Study Backs BlueGnome CGH Arrays as Screening Tool to Improve IVF Success Rates
May 08, 2012
Study Backs BlueGnome CGH Arrays as Screening Tool to Improve IVF Success Rates
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina's Q4 Array Revenues Climb 4 Percent on BlueGnome Addition, HumanCore Demand
January 29, 2013 / BioArray News - BlueGnome Licenses Karyomapping IP in Bid to Bolster Pre-Implantation Genetic-Dx Play
October 19, 2010 / BioArray News - At Investor Confab, Illumina CFO Discusses Sequestration, Japanese Market, BlueGnome
March 12, 2013 / BioArray News - Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News - Pacific Reproductive Center Adopts BlueGnome Arrays for Preimplantation Genetic Screening
May 17, 2011 / BioArray News